Dominari Holdings (FRA:BP2A) Change In Receivables : €-0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Dominari Holdings Change In Receivables?

Dominari Holdings's change in receivables for the quarter that ended in Mar. 2024 was €0.05 Mil. It means Dominari Holdings's Accounts Receivable declined by €0.05 Mil from Dec. 2023 to Mar. 2024 .

Dominari Holdings's change in receivables for the fiscal year that ended in Dec. 2023 was €-0.11 Mil. It means Dominari Holdings's Accounts Receivable increased by €0.11 Mil from Dec. 2022 to Dec. 2023 .

Dominari Holdings's Accounts Receivable for the quarter that ended in Mar. 2024 was €0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Dominari Holdings's Days Sales Outstanding for the three months ended in Mar. 2024 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Dominari Holdings's liquidation value for the three months ended in Mar. 2024 was €2.35 Mil.

Dominari Holdings Change In Receivables Historical Data

The historical data trend for Dominari Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dominari Holdings Change In Receivables Chart

Dominari Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-0.22

-0.57

-0.11

Dominari Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-0.06	-0.03	-	-0.02	0.05

Dominari Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.00 Mil.

Dominari Holdings (FRA:BP2A) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Dominari Holdings's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	1.258	*	91
=	0.00

2. In Ben Graham's calculation of liquidation value, Dominari Holdings's accounts receivable are only considered to be worth 75% of book value:

Dominari Holdings's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	6.513	-	4.163	+	0.75 * 0	+	0.5 * 0
=	2.35

Dominari Holdings Change In Receivables Related Terms

Thank you for viewing the detailed overview of Dominari Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Dominari Holdings (FRA:BP2A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dominari Holdings Inc (FRA:BP2A) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

DOMH:USA BP2A:Germany

Address

One Rockefeller Plaza, 11th Floor, New York, NY, USA, 10020

Website

https://www.dominariholdings.com

Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing a therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore, and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The company is also developing an antiviral platform, in which the compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19.

Dominari Holdings (FRA:BP2A) Headlines

No Headlines